Atsuko Asao

Suggest Changes
Learn More
4142 Background: An open label dose escalation biopsy-based Phase I trial of huA33 in patients with early gastric carcinoma Methods: Thirteen patients were entered onto one of four dose levels (1.0,(More)
  • 1